Home > Boards > US Listed > Biotechs >

Opgen (OPGN)

OPGN RSS Feed 		Add OPGN Price Alert      Hide Sticky   Hide Intro
Moderator: mick
Search This Board: 
Last Post: 9/22/2020 7:58:32 PM - Followers: 71 - Board type: Free - Posts Today: 0



businesses to build stronger diagnostic solutions for severe infections.

https://curetis.com/wp-content/uploads/logo.png";) left center / contain no-repeat transparent; color: rgb(51, 122, 183); text-decoration-line: none; display: block; height: 100px; text-indent: -1000%; width: 100px;">Curetis

Menu

Fast & Simple Syndromic Testing for Severe Infections – Improving Patient Outcomes

 

 

 

Antibiotic resistant microorganisms are a global health threat*

Priority number one is to help detect pathogens rapidly, including associated antibiotic resistance genes

OUR SOLUTION

 

The Unyvero A50 Solution

With the Unyvero A50 Solution, Curetis has developed a molecular diagnostics system for reliable and extremely rapid diagnosis of severe infectious diseases within just 4-5 hours. The system uses powerful multiplex PCR technology and syndromic testing to detect a wide variety of microorganisms, antibiotic resistance markers, or toxins.

RAPID

Results in 4-5 hours versus 1-4 days

SIMPLE

Sample-to-answer, easy workflow

RELIABLE

High sensitivity and specificity for clinically actionable answers

COMPREHENSIVE

Broad syndromic panels for major infectious diseases

 

Unyvero A50 Applications for Major Infectious Disease

HPN — Hospitalized Pneumonia

HPN Solution 

BCU — Blood Culture

Analyzes the DNA of 103 pathogens and resistance genes from a positive blood cultures for fast diagnostics of blood stream infections.

BCU Solution 

IAI — Intra-Abdominal Infection

IAI Solution 

UTI — Urinary Tract Infection

UTI Solution 

ITI — Implant & Tissue Infection

ITI Solution 

 


OpGen, Inc. (NASDAQ: $OPGN) is harnessing the power of informatics and genomic analysis to provide complete solutions for infection prevention and treatment.
LEVEL II
http://markets.cboe.com/us/equities/market_statistics/book/opgn/?mkt=edgx


OPGN -FAIR VALUE $7-$8 SHARE, Subsidiary Ares Genetics Enters Coronavirus Infection Control Race With China Partner BGI Group
Feb. 2, 2020 9:32 AM ET|About: OpGen, Inc. (OPGN),

https://seekingalpha.com/instablog/50857529-johnsoriaknows/5404050-opgn-subsidiary-ares-genetics-enters-coronavirus-infection-control-race-china-partner-bgi

Summary
Opgen is one of the few companies in the US that has announced specific products and services to enter the coronavirus space.

On January 30, 2020 Opgen announced that subsidiary Ares Genetics will collaborate with long-term China partner BGI Group to make molecular tests for coronavirus 2019-nCoV available in Europe in February.







“Curetis GmbH’s subsidiary Ares Genetics’ collaboration with BGI Group to offer Next-Generation Sequencing (NGS) and PCR-based Coronavirus (2019-nCoV) testing in Europe.”

Based on a projected revenue growth of 100% Y/Y to $10M in 2020, fair value should be about $7 - $8/share ($50M Market cap). The current market cap is $9M.



https://www.zerohedge.com/geopolitical/fda-announces-plan-speed-coronavirus-testing-south-korea-reports-huge-jump-new-cases
HISTORY TELLS AH STORY, 

https://curetis.com/products/unyvero-a50-system/



Products https://curetis.com/products/unyvero-a50-system/#unyvero-future

https://otcbb.swingtradebot.com/equities/OPGN:OTC

MEDICINE HEALTH PHARMACEUTICALS POLICY INFECTIOUS DISEASES INFECTION FDA INFECTIONS MOLECULAR DIAGNOSTICS INFECTIOUS DISEASE VETERINARY MEDICINE EVOLUTIONARY BIOLOGY MULTIPLE DRUG RESISTANCE ANTIMICROBIAL RESISTANCE

BGI's COVID-19 test kits approved by US FDA March 29, 2020

http://www.china.org.cn/world/2020-03/29/content_75873279.htm

China's leading genome sequencing provider BGI announced Friday that it has received an emergency use authorization from the U.S. Food and Drug Administration (FDA) for its test kits detecting COVID-19.

It means that the product, named Real-Time Fluorescent RT-PCR Kit for Detecting SARS-2019-nCoV, has obtained the qualification to officially enter the clinical market in the United States, according to BGI's announcement.

The Shenzhen-based company finished R&D of the diagnostic test in mid-January, which has previously received emergency approval from China's National Medical Products Administration, followed by CE-IVD marking.

Yin Ye, CEO of BGI, said the FDA's approval of the test kits will help provide high-quality and high-throughput testing services for people in the United States.

"The nucleic acid testing results will assist screening efforts and enable medical professionals to respond quickly, thus helping curb the spread of the virus," Yin said.

BGI has so far produced more than 7 million test kits and completed testings for nearly 580,000 people in China during the epidemic fight as well as the current nationwide resumption of work and production.

The kits are being used in 70 countries and regions including Japan, Brunei, Thailand, The United Arab Emirates, Egypt and Peru.




https://coronavirus.jhu.edu/map.html





*DISCLAIMER *The Board Monitor and The Board Assistants herewith, are not licensed brokers and assume NO responsibility for the actions, investment decisions, and or messages posted on this forum.
• We do NOT recommend that anyone buy or sell any securities posted herewith. Any trade entered into risks the possibility of losing the funds invested.
• There are no guarantees when buying or selling any security.







 
OPGN
Current Price
Volume:
Bid Ask Day's Range
OPGN Detailed Quote
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
OPGN News: Additional Proxy Soliciting Materials (definitive) (defa14a) 09/18/2020 05:06:35 PM
OPGN News: OpGen, Inc. Announces Notice of Annual Meeting Venue Change 09/18/2020 04:30:10 PM
OPGN News: Collaborative Research by OpGen Group Company Ares Genetics and Johns Hopkins Researchers Demonstrates Potential of Next-Gene... 09/16/2020 07:30:10 AM
OPGN News: Statement of Changes in Beneficial Ownership (4) 09/09/2020 05:32:21 PM
OPGN News: OpGen Group Company Ares Genetics Nominated for Austrian Innovation Award for AI-powered Molecular Antibiotic Susceptibility ... 09/08/2020 07:30:10 AM
PostSubject
#2322  Sticky Note $OPGN # 2 OpGen Co-Markets COVID-19 Antibody Test Kit mick 08/09/20 06:29:05 PM
#2343   OPGN stock reminds me of the story of chillswills37 09/22/20 07:58:32 PM
#2342   OpGen Inc (OPGN) mick 09/05/20 03:07:52 PM
#2341   Classic red green move koming. BEIJING BILL 08/21/20 09:42:32 AM
#2340   Think we end the day 2.85 to 3.00 PennystockID2017 08/20/20 06:58:57 PM
#2339   There goes todays momentum !! inspector joe 08/20/20 06:25:15 PM
#2338   * * $OPGN Video Chart 08-20-2020 * * ClayTrader 08/20/20 04:47:27 PM
#2337   Prior to $4.40 spike, O/S 15.5MM; after spike chillswills37 08/20/20 02:52:19 PM
#2336   News: $OPGN OpGen Announces CE-IVD Marking and Commercial whytestocks 08/20/20 10:30:47 AM
#2335   1 hour from a drop a blood. Better, realfast95 08/20/20 09:36:21 AM
#2334   great pop from $2 level! thanks crude! $treet $inatra 08/20/20 09:33:05 AM
#2333   $OPGN nice pre-market opening mick 08/20/20 08:28:29 AM
#2332   OPGN up 46% > OpGen Announces CE-IVD Marking crudeoil24 08/20/20 08:00:54 AM
#2331   ir.opgen.com/news-releases/news-release-details/opgen-announces-ce-iv symphon1 08/20/20 07:38:37 AM
#2330   This says it all, that is fake news JAH son 08/19/20 08:19:43 PM
#2329   Not issued by OPGEN. "Source: 3 anonymous sources" chillswills37 08/19/20 04:28:05 PM
#2328   Major Pharmaceutical Giant will soon announce a definitive symphon1 08/19/20 07:56:50 AM
#2327   OpGen Inc (OPGN) mick 08/16/20 01:41:09 PM
#2326   Now is the time to buy. Adam712 08/14/20 02:05:42 PM
#2325   So quite here Tony77 08/12/20 12:50:02 AM
#2324   $OPGN payoff time my friend mick 08/09/20 09:59:04 PM
#2323   $OPGN [cash cow] OpGen Reports First Quarter 2020 mick 08/09/20 06:45:30 PM
#2322   $OPGN # 2 OpGen Co-Markets COVID-19 Antibody Test Kit mick 08/09/20 06:29:05 PM
#2321   Let’s go Billydakidd 08/09/20 05:19:36 PM
#2320   News: $OPGN OpGen Co-Markets COVID-19 Antibody Test Kit whytestocks 08/09/20 04:30:24 PM
#2319   $OPGN OpGen Inc (OPGN) mick 08/08/20 12:10:50 AM
#2318   * * $OPGN Video Chart 08-07-2020 * * ClayTrader 08/07/20 04:24:52 PM
#2317   might wanna test the $5-$5.50 area next week $treet $inatra 08/07/20 02:35:00 PM
#2316   congrats to the longs here $OPGN sweet pop https://finance.yahoo.com/news/opgen- $treet $inatra 08/07/20 02:34:01 PM
#2315   Got it, thanks Up_Down 08/07/20 11:56:55 AM
#2314   Tweet: Our 2nd new @ASMicrobiology ASM2020 poster now crudeoil24 08/07/20 11:54:24 AM
#2313   What's making this thing move this morning? I'm Up_Down 08/07/20 11:39:30 AM
#2312   out at 3.30s peterus 08/07/20 11:26:29 AM
#2311   thanks Mick peterus 08/07/20 11:25:50 AM
#2310   VTGN is next - mark it CyrusDaVirus 08/07/20 11:21:40 AM
#2309   $OPGN 3's are hitting mick 08/07/20 11:07:20 AM
#2308   Looks good! yen4dollars 08/07/20 11:04:10 AM
#2307   $OPGN @ finviz Shs Outstand 15.46M - Short Float 7.95% mick 08/07/20 09:55:48 AM
#2306   Mick you know the O/S peterus 08/07/20 09:52:56 AM
#2305   $OPGN OpGen to Provide Business Update and Financial mick 08/07/20 09:49:15 AM
#2304   $OPGN nice pre-market opening mick 08/07/20 09:44:18 AM
#2303   $United States Coronavirus Cases:4,290,235,Deaths:149,046 mick 07/25/20 03:43:53 PM
#2302   $Coronavirus Cases:16,087,202,Deaths:645,309,Recovered:9,827,717 mick 07/25/20 03:41:14 PM
#2301   $OPGN OpGen Inc (OPGN) mick 07/25/20 03:37:58 PM
#2300   Glad it started moving. Just wait for the yen4dollars 07/21/20 11:28:22 AM
#2299   $OPGN https://www.barchart.com/stocks/quotes/OPGN/interactive-chart mick 07/17/20 12:39:44 AM
#2298   $OPGN Key Market Competitors: mick 07/17/20 12:36:05 AM
#2297   $OPGN Menarini Silicon Biosystems Partners with OpGen to mick 07/17/20 12:30:09 AM
#2296   $OPGN OpGen Provides Business Update and Announces Preliminary mick 07/17/20 12:27:05 AM
#2295   United States Coronavirus Cases:3,695,025,Deaths:141,118,Recovered: mick 07/17/20 12:24:54 AM
#2294   $OPGN https://www.barchart.com/stocks/quotes/OPGN/technical-analysis mick 07/17/20 12:21:26 AM
PostSubject
© 2020 InvestorsHub.com, Inc.
Consent Preferences